• Blog
  • Rheumatoid Arthritis Treatment Market Analysis | 2021-2026

    Rheumatoid Arthritis Treatment Market Analysis | 2021-2026

    Rheumatoid Arthritis Treatment Market Analysis | 2021-2026
    Report code - SRHL236 Delivery - 2 Weeks
    Rheumatoid Arthritis Treatment Market Size, Share, Trend, Forecast & Competitive See more...

    Market Insights

    The Rheumatoid Arthritis Treatment Market was estimated at US$ 23.1 billion in 2020 and is expected to grow at a CAGR of 6% during 2021-2026 to reach US$ 32.7 billion by 2026.

    Wish to get a free sample? Register here

    What is Rheumatoid Arthritis?

    Rheumatoid Arthritis is an autoimmune and chronic inflammatory disorder that affects the joints. It can also damage other parts of the body including skin, lungs, heart, eyes, and blood vessels. It happens when the immune system attacks the body tissues by mistake and thus, causes inflammation in the joints.

    Rheumatoid Arthritis Treatment Market Report Overview

    Market Size in 2026

    USD 32.7 Billion

    Market Size in 2020

    USD 23.1 Billion

    Market Growth (2021-2026)

    Over 6%

    Base Year of Study

    2020

    Trend Period

    2015-2019

    Forecast Period

    2021-2026

    Segments Covered

    By Therapy Type (Symptomatic Treatment, Intermediate Corticosteroid Therapies, Disease-Modifying Antirheumatic Drug)

    By Therapies (Conventional DMARDs, Biologic DMARDs)

    By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Drug Stores)

    By Region (North America, Europe, Asia-Pacific, & the Rest of the World)

    Dominant Region

    North America is expected to be dominant throughout the forecast period.

    Market Dynamics

    The growth of the global rheumatoid arthritis treatment market is primarily driven by the increasing prevalence of arthritis particularly among the geriatric populace across geographies.

    • Increasing consumer awareness is expected to bolster market growth significantly.

    • Additionally, the growing emphasis on the development of advanced solutions by the market players is projected to propel market growth at a significant rate during the review period.

    • However, the high cost associated with rheumatoid arthritis treatment is likely to affect the market growth.

    COVID-19 Impact

    The COVID-19 outbreak did affect the growth of the rheumatoid arthritis treatment market negatively due to fear among people that patients having rheumatoid arthritis are more prone to COVID-19 and are likely to face more severe complications. The rheumatoid arthritis patients made significant changes in their medical use amid the COVID-19 outbreak and thus, affected the market growth.

    Segments Analysis

    Therapy Type Trends

    The rheumatoid arthritis market has been segmented into symptomatic treatment, intermediate corticosteroid therapies, and disease-modifying antirheumatic drug (DMARD) therapies.

    • The DMARD segment has been further bifurcated into conventional DMARDs and biologic DMARDs.

    • The DMARD segment accounted for the largest market share in 2020 and is projected to grow at the fastest CAGR during the review period due to the increasing adoption of conventional DMARD therapy to treat rheumatoid arthritis.

    Regional Analysis

    Geographically, the market in North America accounted for the largest market share during the forecast period.

    • The market growth can be attributed to the expanding geriatric populace and the availability of advanced healthcare infrastructure.

    • The market in Asia-Pacific is expected to register the fastest growth during the review period on account of rising consumer awareness and the growing medical tourism industry in developing countries.

    Want to know which region offers the best growth opportunities? Register Here

    Key Players

    The market is highly populated with the presence of several local, regional, and global players. Most of the major players compete in some of the governing factors including price, product offerings, regional presence, etc.

    The following are the key players in the global rheumatoid arthritis treatment market (arranged alphabetically).

    Note: The above list does not necessarily include all the top players in the market.

    Are you the leading player in this market? We would love to include your name. Write to us at sales@stratviewresearch.com

    Report Features

    This report provides market intelligence most comprehensively. The report structure has been kept such that it offers maximum business value. It provides critical insights into the market dynamics and will enable strategic decision-making for the existing market players as well as those willing to enter the market.

    What Deliverables Will You Get in this Report?

    Key questions this report answers

    Relevant contents in the report

    How big is the sales opportunity?

    In-depth Analysis of the Rheumatoid Arthritis Treatment Market 

    How lucrative is the future?

    The market forecast and trend data and emerging trends

    Which regions offer the best sales opportunities?

    Global, regional, and country-level historical data and forecasts

    Which are the most attractive market segments?

    Market Segment Analysis and Forecast

    What are the top players and their market positioning?

    Competitive landscape analysis, Market share analysis

    How complex is the business environment?

    Porter’s five forces analysis, PEST analysis, Life cycle analysis

    What are the factors affecting the market?

    Drivers & challenges

    Will I get the information on my specific requirements?

    10% free customization

    Target Audience

    Here is the list of the group of customers that the market hopes to have the greatest opportunity to convert-

    • Manufacturers
    • Suppliers
    • Distributors
    • Organizations
    • Government bodies

    Research Methodology

    This report offers high-quality insights and is the outcome of a detailed research methodology comprising extensive secondary research, rigorous primary interviews with industry stakeholders, and validation and triangulation with Stratview Research’s internal database and statistical tools. 

    More than 1,000 authenticated secondary sources, such as company annual reports, fact books, press releases, journals, investor presentations, white papers, patents, and articles, have been leveraged to gather the data. 

    We conducted more than 15 detailed primary interviews with the market players across the value chain in all four regions and industry experts to obtain both qualitative and quantitative insights.

    Customization Option

    With this detailed report, Stratview Research offers one of the following free customization options to our respectable clients:

    Company Profiling

    • Detailed profiling of additional market players (up to three players).
    • SWOT analysis of key players (up to three players).

    Competitive Benchmarking

    • Benchmarking of key players on the following parameters: product portfolio, geographical reach, regional presence, and strategic alliances.

    Custom Research: Stratview Research offers custom research services across sectors. In case of any custom research requirement related to market assessment, competitive benchmarking, sourcing and procurement, target screening, and others, please send your inquiry to sales@Stratviewresearch.com.

    Frequently Asked Questions (FAQs)

    The Rheumatoid Arthritis Treatment Market is expected to grow at a CAGR of 6% during 2021-2026.

    Sanofi SA (France), Johnson & Johnson (The U.S), F. Hoffman-La Roche AG (Switzerland), Pfizer Inc. (The U.S), Eli Lilly & Company (The U.S), AbbVie Inc. (The U.S), Sobi Inc. (Sweden), Amgen Inc. (The U.S), UCB S.A. (Belgium) and Bristol-Myers Squibb Company (The U.S) are among the key players in the rheumatoid arthritis treatment market.

    The Rheumatoid Arthritis Treatment Market is expected to reach US$ 32.7 billion by 2026.

    North America is expected to register the fastest growth in the rheumatoid arthritis treatment market in the coming years.

    The increasing prevalence of arthritis particularly among the geriatric populace across geographies, increasing consumer awareness, and growing emphasis on the development of advanced solutions by the market players are the factors driving the growth of the rheumatoid arthritis treatment market.

    Rheumatoid arthritis treatment manufacturers, Rheumatoid arthritis treatment suppliers, Rheumatoid arthritis treatment distributors, Organizations, and Government bodies are the target audience in the rheumatoid arthritis treatment market.